Professor Steve Myint is a medical academic turned businessman and entrepreneur. He is a former Professor & Chairman of Microbiology & Immunology in Leicester (UK) and Dean of Medicine & Head of the Health Schools at the University of Surrey (UK). He is currently an adjunct Professor at Duke-NUS Medical School (Singapore).
In the last decade plus he has been, at first, a corporate executive in SmithKline Beecham and then the largest tech transfer group turned biotech company in the UK, BTG International (now part of Boston Scientific). He was also executive chairman of one of India’s largest vaccine conglomerates (Green SignalBio).
He has been an entrepreneur for over 30 years with 5 successful startups and then mentor of over 30 start-ups and SMEs, mainly in the deep tech space. Successful exits have allowed him to set up crowdfunding, private equity and venture capital vehicles.
He is co-chair of the EAN at the Royal College of Surgeons of England and Chairman of Golden Futures in England and he is chairman of SGVector and INEX Innovate in Singapore. He is also founder of a company and ambassador to an organisation that promote ethical values based in Slovenia.
Most recently he has been appointed the national clinical lead for AMR diagnostics by the UK government. He has been an advisor/committee chairman to several national and international bodies including A*Star and National Research Foundation in Singapore, Bill & Melinda Gates Foundation, National Lotteries Foundation (UK), Finnvera (Finland).